Stoke Therapeutics (STOK)
(Delayed Data from NSDQ)
$14.63 USD
+0.38 (2.67%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $14.64 +0.01 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.46 |
Last EPS Surprise | 19.30% |
ABR | 1.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.23 |
Next Year | -2.59 |
EPS (TTM) | -2.18 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.46M | 2.96M | 14.82M | 11.59M |
# of Estimates | 4 | 4 | 4 | 3 |
High Estimate | 4.00M | 4.00M | 17.05M | 15.00M |
Low Estimate | 2.32M | 2.00M | 11.18M | 8.58M |
Year ago Sales | 3.31M | 2.80M | 8.78M | 14.82M |
Year over Year Growth Est. | 4.38% | 5.54% | 68.79% | -21.82% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.56 | -2.23 | -2.59 |
# of Estimates | 5 | 4 | 6 | 5 |
Most Recent Consensus | -0.51 | -0.51 | -2.11 | -2.91 |
High Estimate | -0.49 | -0.51 | -2.03 | -2.30 |
Low Estimate | -0.67 | -0.69 | -2.58 | -2.91 |
Year ago EPS | -0.55 | -0.60 | -2.38 | -2.23 |
Year over Year Growth Est. | 0.00% | 6.67% | 6.30% | -16.29% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 3 | 4 | 5 |
Up Last 60 Days | 3 | 3 | 4 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.56 | -2.23 | -2.59 |
7 Days Ago | -0.55 | -0.56 | -2.23 | -2.59 |
30 Days Ago | -0.56 | -0.59 | -2.30 | -2.81 |
60 Days Ago | -0.56 | -0.59 | -2.30 | -2.81 |
90 Days Ago | -0.56 | -0.59 | -2.31 | -2.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.56 | -2.20 | -2.59 |
Zacks Consensus Estimate | -0.55 | -0.56 | -2.23 | -2.59 |
Earnings ESP | 0.00% | 0.00% | 1.11% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.46 | -0.57 | -0.60 | -0.55 | NA |
Estimate | -0.57 | -0.60 | -0.62 | -0.65 | NA |
Difference | 0.11 | 0.03 | 0.02 | 0.10 | 0.07 |
Surprise | 19.30% | 5.00% | 3.23% | 15.38% | 10.73% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more